InsidersTradesSigma
Follow the 삼성제약 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 삼성제약 has recorded 1 public disclosures. Market capitalisation: €111.1bn. The latest transaction was filed on 11 March 2026 (Other). Among the most active insiders: 삼성제약. The full history is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Samsung Pharmaceutical is a South Korean company specializing in the healthcare and pharmaceutical sector. It is listed on the KRX.